Relationships between Molecular Complexity, Biological Activity, and Structural Diversity
暂无分享,去创建一个
Peter Ertl | Nathan Brown | Edgar Jacoby | Ansgar Schuffenhauer | Paul Selzer | E. Jacoby | A. Schuffenhauer | P. Selzer | P. Ertl | Nathan Brown
[1] M F Engels,et al. Smart screening: approaches to efficient HTS. , 2001, Current opinion in drug discovery & development.
[2] Hugo O. Villar,et al. Comments on the design of chemical libraries for screening , 2004, Molecular Diversity.
[3] A. Schuffenhauer,et al. Complex molecules: do they add value? , 2005, Current opinion in chemical biology.
[4] A. Hopkins,et al. Ligand efficiency: a useful metric for lead selection. , 2004, Drug discovery today.
[5] Johann Gasteiger,et al. Deriving the 3D structure of organic molecules from their infrared spectra , 1999 .
[6] Valerie J. Gillet,et al. De Novo Molecular Design , 2000 .
[7] Robert Alan Goodnow,et al. Chemoinformatic Tools for Library Design and the Hit‐to‐Lead Process: A User's Perspective , 2005 .
[8] P. Willett,et al. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures. , 2004, Organic & biomolecular chemistry.
[9] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[10] Juan J Perez,et al. Managing molecular diversity. , 2005, Chemical Society reviews.
[11] M. Congreve,et al. Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.
[12] Stephen D. Pickett,et al. Computer‐Aided Molecular Diversity Analysis and Combinatorial Library Design , 2007 .
[13] G. Bemis,et al. The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.
[14] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[15] Johann Gasteiger,et al. Prediction of Aqueous Solubility of Organic Compounds Based on a 3D Structure Representation , 2003, J. Chem. Inf. Comput. Sci..
[16] Robert D. Clark,et al. OptiSim: An Extended Dissimilarity Selection Method for Finding Diverse Representative Subsets , 1997, J. Chem. Inf. Comput. Sci..
[17] Edgar Jacoby,et al. Library design for fragment based screening. , 2005, Current topics in medicinal chemistry.
[18] Darren R. Flower,et al. On the Properties of Bit String-Based Measures of Chemical Similarity , 1998, J. Chem. Inf. Comput. Sci..
[19] Pierre Acklin,et al. The Contribution of Molecular Informatics to Chemogenomics. Knowledge‐Based Discovery of Biological Targets and Chemical Lead Compounds , 2005 .
[20] Meir Glick,et al. Enrichment of Extremely Noisy High-Throughput Screening Data Using a Naïve Bayes Classifier , 2004, Journal of biomolecular screening.
[21] Y. Martin. Diverse viewpoints on computational aspects of molecular diversity. , 2001, Journal of combinatorial chemistry.
[22] W. Guida,et al. The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.
[23] Tudor I. Oprea,et al. Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry , 2005, J. Chem. Inf. Model..
[24] Y. Martin,et al. Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.
[25] Yutaka Endo,et al. Development of a Method for Evaluating Drug-Likeness and Ease of Synthesis Using a Data Set in Which Compounds Are Assigned Scores Based on Chemists' Intuition , 2003, J. Chem. Inf. Comput. Sci..
[26] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[27] Gisbert Schneider,et al. A Hierarchical Clustering Approach for Large Compound Libraries , 2005, J. Chem. Inf. Model..
[28] Gisbert Schneider,et al. Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.
[29] Darren V. S. Green,et al. Computational Chemistry, Molecular Complexity and Screening Set Design , 2005 .
[30] U Schopfer,et al. Molecular diversity management strategies for building and enhancement of diverse and focused lead discovery compound screening collections. , 2004, Combinatorial chemistry & high throughput screening.
[31] George Karypis,et al. A Comparison of Document Clustering Techniques , 2000 .
[32] Gerhard Hessler,et al. Fast similarity searching and screening hit analysis. , 2004, Drug discovery today. Technologies.
[33] Johann Gasteiger,et al. Neural networks in chemistry and drug design , 1999 .
[34] J. Gasteiger,et al. Automatic generation of 3D-atomic coordinates for organic molecules , 1990 .
[35] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[36] I. Kuntz,et al. The maximal affinity of ligands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] Naomie Salim,et al. Analysis and Display of the Size Dependence of Chemical Similarity Coefficients , 2003, J. Chem. Inf. Comput. Sci..
[38] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..